HLC Neonate 6g
HLC Neonate 6g(F) is available by Pharmax.
Features and benefits
Specially formulated for the newborn infant 0 - 12 months
Scientific and usage evidence accepts the HLC organisms as totally safe to use from birth
Contains Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium infantis
No carriers except lactose
Highly concentrated so that only 100mg gives full 3 billion organisms dose
Ability to attach to human epithelial cells
Contains up to 4.5 billion cells per 100mg if stored in a refrigerator until use
3 months shelf life at ambient temperature
2 years shelf life if refrigerated
Independent verification of specification with every batch
Soluble in milk or water
There is now increasing recognition of the critical importance of the correct development of the normal flora in the neonatal human.
From having a sterile G.I. tract at birth, the neonate acquires microbial flora from the first day of life, and this flora is then responsible for a
major part of the development of the entire infant immune system. It is now acknowledged that imbalances in the flora of the neonate may significantly increase the risk of childhood allergy and susceptibility to infectious disease. Consequently, it is now seen as imperative that the infant has a competant composition of microflora from the first day of life and that this can be achieved by supplementation with probiotic organisms daily from birth.
HLC Neonate has been developed specifically for the child up to 12 months of age. It contains the HLC strain of Lactobacillus acidophilus together with Lactobacillus paracasei which appears to be equally
important in establishing the Lactobacillus dominance of the upper intestine. HLC Neonate also contains Bifidobacterium infantis, which, as its name suggests is the strain of Bifidobacterium most suited to the new born infant. L. acidophilus and L. paracasei will target and stimulate the mucosal immune system in the upper part of the G.I. tract and the B. infantis will stimulate the immune system and become established in the lower gut.
THE PHARMAX SOUTH WALES ALLERGY TRIAL HLC
Neonate is currently being used in the largest probiotic intervention trial ever carried out on human neonates. This trial, involving 3000
babies from birth to six months, will prove how effectively HLC Neonate can reduce the incidence of allergy in children. Allergy now effects 1 in 5 children and allergy treatment accounts for about 10% of all prescriptions. The HLC Neonate trial, entirely funded by Pharmax, may well become the definitive trial in childhood allergy prevention.
HLC Neonate is in a very concentrated form so that only 100mg is required to give a full dosage of 3 billion HLC organisms. The only carrier is lactose, which is milk sugar and is assimilable by all infants. The product can be administered to the infant in formula milk, expressed breast milk, or by simply allowing the child to suckle powder from a finger or knuckle that has been dipped into the product.
Typically, per 33mg
Total count 1 billion viable cells